Blitz Briefing - Asia Pac Digital Therapeutics Landscape
We explore the following areas:
- What are some the promising DTx startups in Asia building?
- What therapeutics areas are the focus of DTx in the region?
- Why is DTx of increasing importance to pharmacos, insurers and other verticals?
- What is the right business model for a DTx startup in Asia?
What are Digital Therapeutics? What are Digital Therapeutics not? What qualifies software as therapy? How do we research and develop Digital Therapeutics ? Why can DTx be disruptive? Threats and Opportunities for Pharma
Digital Therapeutics (DTx) - Disruption in HealthcareDr. Mario Weiss
Digital therapeutics is the current disruption in healthcare and GAIA is leading the way. They are delivering effective and fully automated treatments/interventions for global medical needs.
The coming era of digital therapeutics nrc live - sept 2018Chris Hogg
Thoughts on the past, present and future of digital therapeutics and digital medicines. Presentation for NRC Live Zorgtech Conference in Amsterdam, September 2018.
In today’s healthcare market, financial challenges rank as the number one issue hospitals face. To maintain a margin to support their mission, hospital CEOs must always be on the lookout for opportunities to boost revenue through improved reimbursement. In this webinar, Thibodaux Regional Medical Center’s Greg Stock, president and chief executive officer, and Mikki Fazzio, director, HIM and clinical documentation improvement, as they share how Thibodaux Regional leveraged analytics to provide actionable feedback to continuously improve the process, and how you can too.
Managing ‘discharged not final billed’ (DNFB) cases is one important way hospitals can improve financial performance by increasing collection on bills with incomplete payment due to coding or documentation gaps. Historically, Thibodaux Regional’s DNFB caseload had reached 500 cases per month, with about a third of patients discharged without a completed bill due either to missing documentation or incomplete coding. Thibodaux Regional tackled this process problem by expanding the use of analytics to measure and track every aspect of their billing services. The results were impressive and sustainable. Three years after launching its initial DNFB redesign effort, Thibodaux Regional has realized $2.4M in additional annual reimbursement and a 61% relative reduction in DNFB dollars, as well as a 6.2 reduction in AR days, resulting in significantly improved cash flow.
View this webinar to learn how to:
- Increase reimbursement levels by optimizing workflow analytics
- Ease the documentation burden on overloaded physicians with time-efficient communication
- Provide critical analytics visibility to key stakeholders
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
Successfully Managing Chronic Health Conditions with Human-Centered Digital T...Cognizant
By adopting evidence-based digital therapeutics, healthcare organizations can alleviate the mounting costs of caring for patients with chronic conditions — and enter the fourth wave of digital healthcare.
What are Digital Therapeutics? What are Digital Therapeutics not? What qualifies software as therapy? How do we research and develop Digital Therapeutics ? Why can DTx be disruptive? Threats and Opportunities for Pharma
Digital Therapeutics (DTx) - Disruption in HealthcareDr. Mario Weiss
Digital therapeutics is the current disruption in healthcare and GAIA is leading the way. They are delivering effective and fully automated treatments/interventions for global medical needs.
The coming era of digital therapeutics nrc live - sept 2018Chris Hogg
Thoughts on the past, present and future of digital therapeutics and digital medicines. Presentation for NRC Live Zorgtech Conference in Amsterdam, September 2018.
In today’s healthcare market, financial challenges rank as the number one issue hospitals face. To maintain a margin to support their mission, hospital CEOs must always be on the lookout for opportunities to boost revenue through improved reimbursement. In this webinar, Thibodaux Regional Medical Center’s Greg Stock, president and chief executive officer, and Mikki Fazzio, director, HIM and clinical documentation improvement, as they share how Thibodaux Regional leveraged analytics to provide actionable feedback to continuously improve the process, and how you can too.
Managing ‘discharged not final billed’ (DNFB) cases is one important way hospitals can improve financial performance by increasing collection on bills with incomplete payment due to coding or documentation gaps. Historically, Thibodaux Regional’s DNFB caseload had reached 500 cases per month, with about a third of patients discharged without a completed bill due either to missing documentation or incomplete coding. Thibodaux Regional tackled this process problem by expanding the use of analytics to measure and track every aspect of their billing services. The results were impressive and sustainable. Three years after launching its initial DNFB redesign effort, Thibodaux Regional has realized $2.4M in additional annual reimbursement and a 61% relative reduction in DNFB dollars, as well as a 6.2 reduction in AR days, resulting in significantly improved cash flow.
View this webinar to learn how to:
- Increase reimbursement levels by optimizing workflow analytics
- Ease the documentation burden on overloaded physicians with time-efficient communication
- Provide critical analytics visibility to key stakeholders
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
Successfully Managing Chronic Health Conditions with Human-Centered Digital T...Cognizant
By adopting evidence-based digital therapeutics, healthcare organizations can alleviate the mounting costs of caring for patients with chronic conditions — and enter the fourth wave of digital healthcare.
Disruptive Innovation in Health Care: A Path to High Quality, Affordable Care?The Commonwealth Fund
Talk delivered by Eric Schneider, MD, MSc, FACP to the Anthem Advisory Board on April 11, 2018. Dr. Schneider discussed the challenges facing the U.S. health care system and the potential for disruptive innovation.
Why Payers, Providers and Life Science/Pharma Must Join Forces to Achieve Tru...Health Catalyst
Is value-based care (VBC) the path to reducing the 18% of GDP that is spent on healthcare? It just may be, but all parties must play their part. Iya Khalil, chief commercial officer & co-founder at GNS Healthcare argues that in order for VBC to reach peak levels of performance and adoption, there must be a convergence of understanding between three key players: payers, providers and the life science industry.
These three parties have developed lifesaving innovations, tech-enabled new procedures, and advanced medical training that have all contributed over the last half century to push the US economy to spend an unsustainable amount on healthcare. Data and analytics are key to fixing this problem and are transforming the way that healthcare is delivered, however, VBC implementation remains complex. In this webinar Iya and Elia Stupka, SVP and general manager, life sciences business at Health Catalyst discuss how the healthcare industry reached this tipping point, why the move to VBC is so important, and how these parties can jointly work together to make healthcare sustainable.
View the webinar and learn:
- How you can make the move to VBC
- The importance of AI and data to drive VBC
VBC will happen and presents an unprecedented moment for payers, providers and life science groups to work together.
Leveraging Predictive Models to Reduce ReadmissionsHealth Catalyst
Far too often analytics efforts have fallen short of making a tangible impact on outcomes because they haven’t been successfully implemented in real workflows. Predictive models remain at risk of becoming isolated in their use along the continuum of care where their integration may provide benefits larger than the sum of each silo.
To combat this, UnityPoint Health (UPH) focused on integrating analytical models within the same readmission reduction strategy and coaching the care team to facilitate their adoption. Using this approach, one of UPH hospital’s risk-adjusted readmission indexes improved 40 percent over three years, surpassing internal system targets in performance and becoming the top performer in the health system.
Learning Objectives:
- Describe applicable predictive models useful in reducing 30-day readmissions.
- Learn the elements of a successful readmissions reduction strategy in an integrated health system.
- Understand common obstacles faced in the adoption of analytical tools and how to overcome them.
View this webinar to gain knowledge of the analytics tools and methods UPH used, including innovative individualized risk heat-maps generated for each patient, strategies for analytics adoption, and lessons learned along the way.
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
A Reference Architecture for Digital Health: The Health Catalyst Data Operati...Health Catalyst
There are essentially four strategic options to address the enterprise data platform requirements of today’s healthcare systems: (1) build your own, (2) buy from EHR vendors, (3) look to a Silicon Valley high-tech startup, and (4) partner with Health Catalyst or a handful of similar companies.
In this webinar, Health Catalyst’s CTO, Dale Sanders, comments on all four approaches, hoping to help you to assess your organization’s strategy against the options and vendors in each category.
It’s been exactly three years since Health Catalyst embarked on a major investment in its next-generation technology, the Data Operating System (DOS™) and its applications. This webinar is an update on the progress, less about marketing the technology, but rather offering DOS as a reference architecture that can support analytics, AI, text processing, data-first application development, and interoperability, as an all-in-one agile cost-savings architecture.
In addition to the successes, Dale comments on the challenges that Health Catalyst has faced under a very ambitious DOS development plan. In its current state, DOS has made some significant improvements to overcome early mistakes, and is now a very solid enterprise data platform. In the interests of industry-wide learning, Sanders will talk transparently about those mistakes and how those learnings are being applied to the DOS platform, positioning it to evolve gracefully over the next 25 years.
View the webinar to learn how the DOS reference architecture:
- Helps manage the 2,000+ compulsory measures in US healthcare
- Enables applications as varied as a real-time patient safety surveillance system, and an activity-based costing system in one platform
- Can ingest data of any type or velocity from over 300 healthcare source systems and growing
- Bundles tools, applications, and analytics that would cost 3-6x more to build on your own
- Compares to EHR vendors as an option to serve as an enterprise data and analytics platform
- Is a performant, sustainable, and maintainable platform for deploying AI models in the natural flow of the healthcare data pipeline
- Provides curated data content and models while still allowing for the agility of a late binding design option
- Functions as a reference architecture that all healthcare organizations and vendors will ultimately have to build in their pursuit of digital health
Healthcare Analytics: Right-Brain Advice in a Left-Brain WorldHealth Catalyst
U.S. healthcare is badly missing the soft, human side of healthcare analytics, especially as it impacts clinicians. How do we fix that? This webinar explores those ideas.
You won’t hear Dale talk about SQL, inner joins, outer joins, R, Python, logistic regression, random forest, or convolutional neural networks but instead, in this webinar he talks about the principles and philosophy of analytics.
For the most part, we’ve figured out the technology of analytics. That is all left-brain thinking—analytical, logical and methodical in nature—and it is literally getting easier every day with new data technology. But, in healthcare, we’re missing the right-brain thinking—creative and artistic in nature—that has almost nothing to do with technology but has everything to do with the human side of pursuing “data driven healthcare.”
Right-brain thinking is required for the oddities and shortcomings of healthcare data, and how to manage those shortcomings in the context of delivering data to the humans who we hope will consume it. The right-brain relates to the personality characteristics of the people who are leading your analytics strategy. It relates to the leadership culture of the organization and where that culture resides on a scale of transparency, internally and externally. The right-brain relates to behavioral economics, evolutionary psychology, human decision making theories, and the fundamental factors that motivate or demotivate human behavior. The right-brain relates to concepts like experimental design and PICO—patients, interventions, comparisons, and outcomes—that, if followed, can make your analytics more truthful and believable. It has to do with the way we negotiate and structure performance-based contracts that are loaded with quality metrics that either measure things that can’t be measured accurately or may measure the wrong thing, altogether.
You see, right-brained thinking in this left-brain world of analytics relates to a bunch of things, but mostly it relates to the Golden Rule of Data. Do unto others with data as you would have them do unto you.
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Good surfers are the consummate analysts. They dynamically process streams of seemingly unrelated information bypassing lesser opportunities, then strategically selecting the perfect wave.
The ability to tease out genuine opportunities amidst a tumult of noise is a hallmark of great analysts. By viewing these slides you will learn:
- The human elements of a great analyst.
- How to re-frame the role of technology in analysis.
- Healthcare knowledge required to maximize the value of a healthcare analyst.
John Wadsworth's (Senior Vice President of Client Engagement, Health Catalyst) engaging presentation style leverages simple and fun analogies to galvanize key concepts for technical, clinical, and executive audiences alike. Join us as he brings principles from the world of surfing and applies them to healthcare analytics.
Embracing game-changing trends and innovations across telehealth, SDOH data integration, AI and gene editing is a great way to build on a promise of a better tomorrow. Go through this presentation to know the top healthcare trends to embrace in 2021.
Agnostic Analytics Solutions vs. EHRs: Six Reasons EHRs Can’t Deliver True He...Health Catalyst
As enterprisewide analytics demands grow across healthcare, health systems that rely on EHRs from major vendors are hitting limitations in their analytics capabilities. EHR vendors have responded with custom and point-solution tools, but these tend to generate more complications (e.g., multiple data stores and disjointed solutions) than analytics interoperability.
To get value out of existing EHRs while also evolving towards more mature analytics, health systems must partner with an analytics vendor that provides an enterprise data management and analytics platform as well as deep improvement implementation experience. Vendor tools and expertise will help organizations leverage their EHRs to meet population health management and value-based payment goals, as well as pursue some of today’s top healthcare strategic goals:
Growth.
Innovation.
Digitization.
Mark Behl Presents: 3 Up-and-Coming Digital Health Companies That Put Patient...Mark Behl
The biggest obstacle to population health innovation is existing legacy systems. By putting patient experience first, three startups are exemplifying what is possible in digital health.
The Smart Health Centers project places trained health information specialists (Navigators) in traditional and non-traditional health facilities to assist patients in connecting to their own medical records and find reliable information about their own conditions. All Navigators are trained in the Smart Health Center Model using this training guide.
Alex Ermolaev at AI Frontiers : Major Applications of AI in HealthcareAI Frontiers
The latest AI advances have the potential to massively improve our health and well being. However, most of the work is yet to be done. In this talk, we will explore the most important opportunities for AI in healthcare. For example, we will explore how AI can diagnose major life-threatening conditions even before those conditions emerge. We will talk about AI ability to recommend dramatically more effective and less harmful treatment plans based on AI understanding of patient's medical history and current conditions. Finally, we will talk about AI role in making our healthcare system effective and affordable for everyone.
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Because everyone matters.
IBM Health and Social Programs Summit, October 2014
Stephen Morgan
Senior Vice President and Chief Medical Officer
Carilion Clinic
Jianying Hu
Research Staff Member and Manager of Healthcare Analytics Research
IBM
Paul Grundy
Global Director of Healthcare Transformation
IBM
Disruptive Innovation in Health Care: A Path to High Quality, Affordable Care?The Commonwealth Fund
Talk delivered by Eric Schneider, MD, MSc, FACP to the Anthem Advisory Board on April 11, 2018. Dr. Schneider discussed the challenges facing the U.S. health care system and the potential for disruptive innovation.
Why Payers, Providers and Life Science/Pharma Must Join Forces to Achieve Tru...Health Catalyst
Is value-based care (VBC) the path to reducing the 18% of GDP that is spent on healthcare? It just may be, but all parties must play their part. Iya Khalil, chief commercial officer & co-founder at GNS Healthcare argues that in order for VBC to reach peak levels of performance and adoption, there must be a convergence of understanding between three key players: payers, providers and the life science industry.
These three parties have developed lifesaving innovations, tech-enabled new procedures, and advanced medical training that have all contributed over the last half century to push the US economy to spend an unsustainable amount on healthcare. Data and analytics are key to fixing this problem and are transforming the way that healthcare is delivered, however, VBC implementation remains complex. In this webinar Iya and Elia Stupka, SVP and general manager, life sciences business at Health Catalyst discuss how the healthcare industry reached this tipping point, why the move to VBC is so important, and how these parties can jointly work together to make healthcare sustainable.
View the webinar and learn:
- How you can make the move to VBC
- The importance of AI and data to drive VBC
VBC will happen and presents an unprecedented moment for payers, providers and life science groups to work together.
Leveraging Predictive Models to Reduce ReadmissionsHealth Catalyst
Far too often analytics efforts have fallen short of making a tangible impact on outcomes because they haven’t been successfully implemented in real workflows. Predictive models remain at risk of becoming isolated in their use along the continuum of care where their integration may provide benefits larger than the sum of each silo.
To combat this, UnityPoint Health (UPH) focused on integrating analytical models within the same readmission reduction strategy and coaching the care team to facilitate their adoption. Using this approach, one of UPH hospital’s risk-adjusted readmission indexes improved 40 percent over three years, surpassing internal system targets in performance and becoming the top performer in the health system.
Learning Objectives:
- Describe applicable predictive models useful in reducing 30-day readmissions.
- Learn the elements of a successful readmissions reduction strategy in an integrated health system.
- Understand common obstacles faced in the adoption of analytical tools and how to overcome them.
View this webinar to gain knowledge of the analytics tools and methods UPH used, including innovative individualized risk heat-maps generated for each patient, strategies for analytics adoption, and lessons learned along the way.
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
A Reference Architecture for Digital Health: The Health Catalyst Data Operati...Health Catalyst
There are essentially four strategic options to address the enterprise data platform requirements of today’s healthcare systems: (1) build your own, (2) buy from EHR vendors, (3) look to a Silicon Valley high-tech startup, and (4) partner with Health Catalyst or a handful of similar companies.
In this webinar, Health Catalyst’s CTO, Dale Sanders, comments on all four approaches, hoping to help you to assess your organization’s strategy against the options and vendors in each category.
It’s been exactly three years since Health Catalyst embarked on a major investment in its next-generation technology, the Data Operating System (DOS™) and its applications. This webinar is an update on the progress, less about marketing the technology, but rather offering DOS as a reference architecture that can support analytics, AI, text processing, data-first application development, and interoperability, as an all-in-one agile cost-savings architecture.
In addition to the successes, Dale comments on the challenges that Health Catalyst has faced under a very ambitious DOS development plan. In its current state, DOS has made some significant improvements to overcome early mistakes, and is now a very solid enterprise data platform. In the interests of industry-wide learning, Sanders will talk transparently about those mistakes and how those learnings are being applied to the DOS platform, positioning it to evolve gracefully over the next 25 years.
View the webinar to learn how the DOS reference architecture:
- Helps manage the 2,000+ compulsory measures in US healthcare
- Enables applications as varied as a real-time patient safety surveillance system, and an activity-based costing system in one platform
- Can ingest data of any type or velocity from over 300 healthcare source systems and growing
- Bundles tools, applications, and analytics that would cost 3-6x more to build on your own
- Compares to EHR vendors as an option to serve as an enterprise data and analytics platform
- Is a performant, sustainable, and maintainable platform for deploying AI models in the natural flow of the healthcare data pipeline
- Provides curated data content and models while still allowing for the agility of a late binding design option
- Functions as a reference architecture that all healthcare organizations and vendors will ultimately have to build in their pursuit of digital health
Healthcare Analytics: Right-Brain Advice in a Left-Brain WorldHealth Catalyst
U.S. healthcare is badly missing the soft, human side of healthcare analytics, especially as it impacts clinicians. How do we fix that? This webinar explores those ideas.
You won’t hear Dale talk about SQL, inner joins, outer joins, R, Python, logistic regression, random forest, or convolutional neural networks but instead, in this webinar he talks about the principles and philosophy of analytics.
For the most part, we’ve figured out the technology of analytics. That is all left-brain thinking—analytical, logical and methodical in nature—and it is literally getting easier every day with new data technology. But, in healthcare, we’re missing the right-brain thinking—creative and artistic in nature—that has almost nothing to do with technology but has everything to do with the human side of pursuing “data driven healthcare.”
Right-brain thinking is required for the oddities and shortcomings of healthcare data, and how to manage those shortcomings in the context of delivering data to the humans who we hope will consume it. The right-brain relates to the personality characteristics of the people who are leading your analytics strategy. It relates to the leadership culture of the organization and where that culture resides on a scale of transparency, internally and externally. The right-brain relates to behavioral economics, evolutionary psychology, human decision making theories, and the fundamental factors that motivate or demotivate human behavior. The right-brain relates to concepts like experimental design and PICO—patients, interventions, comparisons, and outcomes—that, if followed, can make your analytics more truthful and believable. It has to do with the way we negotiate and structure performance-based contracts that are loaded with quality metrics that either measure things that can’t be measured accurately or may measure the wrong thing, altogether.
You see, right-brained thinking in this left-brain world of analytics relates to a bunch of things, but mostly it relates to the Golden Rule of Data. Do unto others with data as you would have them do unto you.
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Good surfers are the consummate analysts. They dynamically process streams of seemingly unrelated information bypassing lesser opportunities, then strategically selecting the perfect wave.
The ability to tease out genuine opportunities amidst a tumult of noise is a hallmark of great analysts. By viewing these slides you will learn:
- The human elements of a great analyst.
- How to re-frame the role of technology in analysis.
- Healthcare knowledge required to maximize the value of a healthcare analyst.
John Wadsworth's (Senior Vice President of Client Engagement, Health Catalyst) engaging presentation style leverages simple and fun analogies to galvanize key concepts for technical, clinical, and executive audiences alike. Join us as he brings principles from the world of surfing and applies them to healthcare analytics.
Embracing game-changing trends and innovations across telehealth, SDOH data integration, AI and gene editing is a great way to build on a promise of a better tomorrow. Go through this presentation to know the top healthcare trends to embrace in 2021.
Agnostic Analytics Solutions vs. EHRs: Six Reasons EHRs Can’t Deliver True He...Health Catalyst
As enterprisewide analytics demands grow across healthcare, health systems that rely on EHRs from major vendors are hitting limitations in their analytics capabilities. EHR vendors have responded with custom and point-solution tools, but these tend to generate more complications (e.g., multiple data stores and disjointed solutions) than analytics interoperability.
To get value out of existing EHRs while also evolving towards more mature analytics, health systems must partner with an analytics vendor that provides an enterprise data management and analytics platform as well as deep improvement implementation experience. Vendor tools and expertise will help organizations leverage their EHRs to meet population health management and value-based payment goals, as well as pursue some of today’s top healthcare strategic goals:
Growth.
Innovation.
Digitization.
Mark Behl Presents: 3 Up-and-Coming Digital Health Companies That Put Patient...Mark Behl
The biggest obstacle to population health innovation is existing legacy systems. By putting patient experience first, three startups are exemplifying what is possible in digital health.
The Smart Health Centers project places trained health information specialists (Navigators) in traditional and non-traditional health facilities to assist patients in connecting to their own medical records and find reliable information about their own conditions. All Navigators are trained in the Smart Health Center Model using this training guide.
Alex Ermolaev at AI Frontiers : Major Applications of AI in HealthcareAI Frontiers
The latest AI advances have the potential to massively improve our health and well being. However, most of the work is yet to be done. In this talk, we will explore the most important opportunities for AI in healthcare. For example, we will explore how AI can diagnose major life-threatening conditions even before those conditions emerge. We will talk about AI ability to recommend dramatically more effective and less harmful treatment plans based on AI understanding of patient's medical history and current conditions. Finally, we will talk about AI role in making our healthcare system effective and affordable for everyone.
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Because everyone matters.
IBM Health and Social Programs Summit, October 2014
Stephen Morgan
Senior Vice President and Chief Medical Officer
Carilion Clinic
Jianying Hu
Research Staff Member and Manager of Healthcare Analytics Research
IBM
Paul Grundy
Global Director of Healthcare Transformation
IBM
Digital technologies are now integral to daily life, and the world’s population has never been more interconnected. Innovation, particularly in the digital sphere, is happening at unprecedented scale. Even so, its application to improve the health of populations remains largely untapped, and there is immense scope for use of digital health solutions.
WHO is harnessing the power of digital technologies and health innovation to accelerate global attainment of health and the well-being.
The purpose for a Global Strategy on Digital Health is to promote healthy lives and wellbeing for everyone, everywhere, at all ages. To deliver its potential, national or regional Digital Health initiatives must be guided by a robust Strategy that integrates financial, organizational, human and technological resources.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
> Digital health explosion
> What is ‘Digital Therapeutics’ (DTx)?
> History of DTx
> Digital Therapeutics Alliance (DTA)
> How does DTx work?
> Disease Mx via DTx
> Barriers in the adoption of DTx
> DTx market
> DTx in the post-COVID era
> DTx market boom in post-COVID era
> Future of DTx
> Regulatory aspects of DTx - USFDA
> DTx incorporation guidance by other regulators
> Conclusion
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform removes silo barriers to connect, aggregate and integrate disparate data from mHealth applications and Remote Patient Monitoring (RPM) devices.
Our services provide HIPAA secure data to the “point of care” wherever the clinician is located. Enabling clinicians to rapidly respond to clinically relevant patient health information can facilitate early interventions, reduce hospital admissions, improve outcomes and lower costs.
Our passion empowers us to create eHealth collaboration tools that enhance provider efficiencies, track outcomes and improve the quality of life for patients throughout the continuum of care.
Why Digital Therapeutics and Patient Engagement Strategies Are a Must-Have fo...Health Catalyst
Life sciences organizations develop meaningful digital therapeutics (DTx) that reach rural communities, treat common chronic diseases, and connect patients to providers through technology that supports clinical journeys. This article shares how incorporating digital engagement tools drives the continuous use of DTx for equitable healthcare.
Development and Co-Commercialization for Emerging Biotech organizationsIndegene
Develop, launch and market your product with an experienced partner. Innovative, technology-led, purpose-built, end-to-end and individual development and commercialization solutions from Phase 2 clinical trials to Loss Of Exclusivity (LOE) for a more effective, sustained, and higher peak revenue.
Clinical Biometrics, Inc. Executive Overview
Description Clinical Biometrics is an organization dedicated to enabling predictive healthcare and disease prevention with the IoT. We are working on the IoT (Internet of Things) wireless, biomedical patient monitoring and vendor agnostic integration, pioneering programmable biosensors, integration products and services to monitor secure clinical data in real-time and over time, for inpatient and outpatient environments. Our model enables predictive and preventative healthcare delivery. We are developing vendor agnostic middleware that will allow the integration of the various vendor's sensors and protocols into a common platform with rich data analytics capabilities. This technology will impact our healthcare paradigms and usher us into the future of healthcare delivery including real-time predictive healthcare and disease prevention.
- Tim Crammer, CEO
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...EY
Summary: This keynote address presented by Pamela Spence, EY Global Life Sciences Leader (pspence2@uk.ey.com) at MAPS 2018 – the annual meeting for Medical Affairs Professional Society – discusses our latest life sciences report and the industry demands for a customer-focused, data driven approach to health care. We describe the accelerating pace of change as technological advances and the escalating expectations of payers, physicians and patient consumers are combining to disrupt the life sciences business model. Data and algorithms that maximize health outcomes based on individual needs and preferences are becoming the ultimate health care consumable. To create value now and in a future that we call Life Sciences 4.0, life sciences companies must build – or participate in – interoperable information systems that collect, combine and share data. For more on our report, Progressions 2018 – Life Sciences 4.0, please go to www.ey.com/progressions
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
For the HIMSS Delaware Valley Chapter. solve a problem; prototype, pilot, adopt and scale. FDA regulations, evidence, health behavior change, data integration
- HealthTech innovation is disrupting healthcare and its established players
- Technology is driving a new paradigm to create better health care
- Developing markets can leapfrog their healthcare infrastructure limitations
- New opportunities are opening to shape the new paradigm
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Innovating for health mObile Health perspectiveRuchi Dass
In the face of the enormous challenges of managing chronic diseases, delivery innovations appear to have the most impact when multiple parties (e.g., physicians, nurses, payors) interact seamlessly to provide the best possible patient care over an extended period of time. Such integrated models have the potential to reduce costs dramatically, while increasing patient satisfaction and clinical quality
This is an analysis of the communication and marketing strategy, SWOT analysis and general company description for Proteus ad Helius, a digital health patch to monitor your medicine intake online.
Similar to Galen Growth Asia | Digital Therapeutics in Asia | Webinar (20)
Asia HealthTech Investment Landscape FY2019Galen Growth
Asia Pac HealthTech ecosystem momentum continues despite geopolitical and domestic headwinds at US$5B invested, across 340 deals, well ahead of our forecast last October. Accordingly, we estimate total global funding in 2019 to exceed US$15B.
Galen Growth Asia HealthTech Summit 2018 | Asia HealthTech Key TrendsGalen Growth
Opening keynote from the Galen Growth Asia HealthTech Summit
Overview of the key trends in the Asia Pac HealthTech ecosystem which has exceeded $5B of funding deployed in first 9 months of the year.
Insurance | Stratifying risk using wearable data | MunichReGalen Growth
Using wearables for insurance risk assessment. MunichRe concludes that there is strong evidence that physical activity as measured by steps per day can effectively segment mortality risk
Asia Pacific Corporate Health Landscape | Galen Growth AsiaGalen Growth
Corporate Health is a key driver in the transformation of healthcare in Asia. HealthTech innovation offers employers and employees with a wealth of resources to enable this transformation. Galen Growth Asia showcases the corporate health solutions landscape.
Asia HealthTech Investment Landscape 2017 Full Year reportGalen Growth
We are pleased to share the 2017 Full Year Asia HealthTech Investment Landscape report, a full update of our most popular report in 2017.
As we predicted last July, 2017 was a record-breaking year for HealthTech in Asia Pacific with funding exceeding the US$2.6B mark! Asia also saw a landmark of 230 deals executed in 2017, thus doubling 2016’s total.
Galen Growth Asia HealthTech Investment Landscape H1 2017Galen Growth
The Asia HealthTech Investment Landscape H1 2017 Report is based on a comprehensive funding analysis based on Galen Growth Asia unique HealthTech startup database, and estimates that venture funding of HealthTech companies in 2016 and H1 2017 almost reached the $4B mark, across over 240 deals. This clearly demonstrates that the Asia HealthTech sector is scaling fast!
A.Schumacher (2017) Blockchain & Healthcare: A Strategy GuideGalen Growth
The healthcare industry needs a revolution – and it is here now. Trusted and open R&D processes, auditable & secure transactions between parties, authenticated by mass collaboration and powered by collective self-interest, rather than by fewer and fewer pharmaceutical giants motivated by profit alone. This healthcare ecosystem is immune to exorbitant drug prices, tampering, fraud, or political control. The name of the technology that makes all this happen is blockchain, a tool that will fundamentally change the healthcare sector. Blockchain will prove to be indispensable in building a global precision-medicine ecosystem that optimally connects patients, clinicians, researchers, insurers and clinical laboratories to one another.
The number of startups entering the healthcare AI space has increased in recent years, with over 50 companies raising their first equity rounds since January 2015. Deals to healthcare-focused AI startups went up from less than 20 in 2012 to nearly 70 in 2016.
'The Digital Healthcare Leap' highlights insights into how digital health could be an answer to the emerging markets’ challenge to achieve sustainable growth; and leapfrog the developed nations to provide quality, affordable, universal and patient-centric care.
With increased internet and smartphone penetration, and the arrival of new affordable technological solutions in the market, digital healthcare will eventually become a fundamental business imperative. The challenge to healthcare providers for the future, is to adapt and set strategies that leverage new technology while putting patients at the heart of everything they do.
Powering the Future of Healthcare in Asia Pacific | Full ReportGalen Growth
How technology will change healthcare delivery
1) The creative destruction of healthcare
2) Data driven healthcare
3) Funding
4) Disruption in Healthcare
5) Opportunity to leapfrog to accelerate change
Galen Growth Asia RESI 2017 PresentationGalen Growth
- Asia health systems are diverse in their needs and pain points
- Asia represents a significant opportunity for healthcare innovators
- HealthTech is an unprecedented opportunity for Asia to transform patient outcomes
- Asia’s HealthTech ecosystem is nascent but thriving
- Galen Growth Asia is the healthtech catalyst in Asia
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.